ArticleOncology2024

Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery.

Nozomu Motono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.